rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    LEGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Legend Biotech: The Market Is Missing The Bigger Picture (NASDAQ:LEGN)
      Nov 17Seeking AlphaLEGN
      Is Legend Biotech (LEGN) Reasonable After CARVYKTI Sales Growth?
      Nov 12Yahoo FinanceLEGN
      H.C. Wainwright reiterates Legend Biotech stock rating at buy
      Nov 11Investing.comLEGN
      What Legend Biotech (LEGN) Said on Its Q3 Earnings Call
      Nov 10Yahoo FinanceLEGN
      Legend Biotech Q3 2026 slides: path to profit amid EPS volatility
      Nov 10Investing.comLEGN
      Legend Biotech Q3 2026 Earnings Call Transcript
      Nov 10BenzingaLEGN
      Earnings call transcript: Legend Biotech Q3 2026 profit progress overshadowed by EPS miss
      Nov 10Investing.comLEGN
      Why is Legend Biotech stock sliding today?
      Nov 10Investing.comLEGN
      Legend Biotech earnings missed by $0.13, revenue topped estimates
      Nov 10Investing.comLEGN
      Legend Biotech shares fall 2% despite revenue beat
      Nov 10Investing.comLEGN
      Legend Biotech in spotlight: Earnings test profit momentum
      Nov 9Investing.comLEGN
      H.C. Wainwright reiterates Legend Biotech stock rating at buy
      Oct 30Investing.comLEGN
      Legend Biotech Corporation Sponsored ADR (LEGN) Recently Broke Out Above the 200-Day Moving Average

      Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?

      Oct 29Yahoo FinanceLEGN
      Legend Biotech (LEGN) Stock Could Trade Below Its Sales Backdrop
      Oct 28Yahoo FinanceLEGN
      Legend Biotech Corporation Sponsored ADR (LEGN) Crossed Above the 50-Day Moving Average: What That Means for Investors

      Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?

      Oct 27Yahoo FinanceLEGN
      Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
      Oct 27Yahoo FinanceLEGN
      Legend Biotech Stock: CARVYKTI Makes Billions, But The Profits Are Elusive (NASDAQ:LEGN)
      Oct 22Seeking AlphaLEGN
      Legend Biotech: CARVYKTI Makes Billions, But The Profits Are Elusive (NASDAQ:LEGN)
      Oct 21Seeking AlphaLEGN
      Legend Holdings (SEHK:3396) Stock Looks Reasonable After A 169% Run
      Oct 18Yahoo FinanceLEGN
      Legend Biotech Receives FDA Clearance for In Vivo CAR-T Therapy Trial
      Oct 15Yahoo FinanceLEGN
      H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales
      Oct 15Investing.comLEGN
      Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and UnitedHealth (UNH)

      Detailed price information for Unitedhealth Group (UNH-N) from The Globe and Mail including charting and trades.

      Oct 15The Globe and MailLEGN
      Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Legend Biotech (LEGN) and Bristol-Myers Squibb (BMY)

      Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

      Oct 10The Globe and MailLEGNBMYLLY
      Legend Biotech (LEGN) Tests Its Valuation After Fresh CARVYKTI Five Year Data
      Oct 4Yahoo FinanceLEGN
      Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

      Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

      Oct 3The Globe and MailLEGNNVST
      Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

      Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as

      Oct 2Yahoo FinanceLEGNUBS
      Legend Biotech launches grant program for myeloma research
      Oct 1Investing.comLEGN
      Legend Biotech Insider Sold Shares Worth $258,920, According to a Recent SEC Filing
      Oct 1Yahoo FinanceLEGN
      H.C. Wainwright reiterates Legend Biotech stock rating on durability data
      Sep 30Investing.comLEGN
      Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Ocugen (OCGN)

      Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailJAZZLEGNOCGN
      H.C. Wainwright reiterates Legend Biotech stock rating on durability data
      Sep 28Investing.comLEGN
      Legend Biotech reports 5-year CARVYKTI data in myeloma patients
      Sep 25Investing.comLEGN
      Can Legend Biotech (LEGN) Turn Cell Therapy Scale Into Compounding Wealth?

      Legend Biotech (NASDAQ:LEGN) presents a compelling equity thesis centered on transforming breakthrough oncology innovation into a high-margin, cash-generative cell therapy franchise. Maintaining a fortress balance sheet anchored by approximately $965 million in cash, cash equivalents, and time deposits as of June 30, fortified by $212 million in net proceeds from a public offering of American […]

      Sep 25Yahoo FinanceLEGN
      Legend Biotech CFO Carlos Santos sells $49,630 in shares
      Sep 23Investing.comLEGN
      Legend Biotech taps Novartis veteran Zhang as CEO
      Sep 15ReutersLEGNNVS
      Legend Names Novartis Executive as CEO
      Sep 15WSJLEGNNVS
      Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

      Ingrid Zhang, an accomplished global biopharmaceutical leader, joins Legend Biotech following a comprehensive Board-led search processBRIDGEWATER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) ("Legend Biotech" or the "Company"), a global leader in cell therapy, today announced that its Board of Directors has appointed Ingrid Zhang as Chief Executive Officer, effective September 15, 2026. Ingrid Zhang succeeds Alan Bash, who has served as Interim Chief Execut

      Sep 15Yahoo FinanceLEGN
      Legend Biotech Appoints Ingrid Zhang as CEO
      Sep 15Yahoo FinanceLEGN
      Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
      Sep 10Yahoo FinanceLEGN
      H.C. Wainwright reiterates Legend Biotech stock rating at buy
      Sep 4Investing.comLEGN
      Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?

      Legend Biotech (LEGN) drew fresh investor attention after announcing that interim CEO Alan Bash will speak at the Morgan Stanley Global Healthcare Conference on September 15, 2026. The company plans to highlight its CAR-T focus and commercial footprint during the event. Legend Biotech’s share price has been volatile, with a 13.91% 1 month share price return, followed by a 41.27% decline over 3 months and a 38.25% fall in 1 year total shareholder return. This suggests that long term momentum...

      Sep 2Yahoo FinanceLEGN
      Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

      BRIDGEWATER N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026, at 2:35 p.m. ET. The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of the Legend Bi

      Sep 1Yahoo FinanceLEGN

      This is the newest page. Registered accounts read further back.